---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171086"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2022-06-09T23:59:59+00:00"
generated_at: "2026-06-25T03:13:45.150448+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences stockholders approve reverse stock split and authorized share increase

## Summary
- Elected Class I directors Huffines, Nagendran, Shah with ~65.9M votes each.
- Ratified PricewaterhouseCoopers as auditor for FY2022: 87.3M for, 226.9K against.
- Approved reverse stock split at ratio of 1:5 to 1:15, board to set exact ratio before 2023 annual meeting.
- Approved increase in authorized shares to 300M multiplied by 3x the reverse split ratio.
- Reverse split and share increase subject to board discretion; may be abandoned.

## SEC filing metadata
- accession: 0001193125-22-171086
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2022-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312522171086/0001193125-22-171086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312522171086/d344917d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171086
- JSON: https://secwatch.observer/filing/0001193125-22-171086.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.